Case Study
Empowering CDMOs: Critical Tech Transfer Success Story
Hear from Megan Embrey, Senior Field Applications Scientist, as she discusses how her commitment and scientific knowledge helped in uncovering a significant flaw in the transfer process from one of our partners to a CDMO. Timeliness was crucial as patients relied on the therapy and required a immediate resolution. After a few days on-site, she successfully pinpointed the problem, trained the operators, and refined their Standard Operating Procedures (SOPs).
Megan Embrey
Senior Field Applications Scientist
Leverage MaxCyte’s pioneering expertise in cell therapy to accelerate product development and de-risk manufacturing
Employing our clinically-validated electroporation platform you can expedite process optimization and seamlessly transition to the clean room.
Our meticulously designed consumables maximize cell recovery to help achieve therapeutic dose.
With partnerships established with 25 leading biotech companies, our unmatched scientific and regulatory support help you navigate technical and regulatory hurdles.
Understanding Flow Electroporation
Electroporation is a non-viral transfection technique that uses electricity to relax cell membranes, allowing payload to enter. Our Flow Electroporation technology is uniquely designed to allow cells to flow through the processing chamber where discrete volumes are electroporated, then collected on a continual basis. This pioneering innovation makes genetic engineering at large scale a reality.
